Inactive Instrument
Protide Pharmaceuticals, Inc. Share Price
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 17/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 886K | |
| -2.01% | -7.86% | +60.74% | +70.97% | 70.44B | |
| +3.84% | -10.61% | +6.97% | +57.43% | 50.31B | |
| +3.35% | +1.60% | +10.58% | +40.01% | 47.51B | |
| +0.51% | +1.51% | +27.96% | +31.43% | 42.91B | |
| +2.70% | -3.66% | +307.41% | +547.01% | 40.39B | |
| +0.69% | -3.44% | +9.52% | +96.59% | 39.69B | |
| +0.06% | -1.43% | +10.47% | +43.27% | 30.59B | |
| -2.95% | -14.09% | +37.94% | +1.30% | 26.8B | |
| -0.39% | -6.92% | -13.60% | -14.40% | 22.36B | |
| Average | +8.91% | -5.43% | +50.89% | +97.07% | 41.22B | |
| Weighted average by Cap. | +0.76% | -5.29% | +54.33% | +102.70% |
Employees
3
